We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Roche May Face Fine in EU Over Alleged Pharmacovigilance Shortfalls
Roche May Face Fine in EU Over Alleged Pharmacovigilance Shortfalls
November 9, 2012
The European Medicines Agency (EMA) has initiated its first-ever infringement procedure against a drugmaker, alleging Roche did not report potential adverse events for 19 of its U.S. drugs.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor